Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LEVONORGESTREL ADALVO 1,5 MG COMPRIMIDO EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LEVONORGESTREL ADALVO 1,5 MG COMPRIMIDO EFG

Approved

STANDARD

LEVONORGESTREL ADALVO 1,5 MG COMPRIMIDO EFG

Adalvo Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 17, 2024
Approval ID: f7fdf5d0178969c2
Company: Adalvo Limited
Type: Standard

Approval Details

Approval Id: f7fdf5d0178969c2
Drug Cima Aemps Name: LEVONORGESTREL ADALVO 1,5 MG COMPRIMIDO EFG
Register Number: 89575
Holder Company Name: Adalvo Limited
Marketing Company Name: Adalvo Limited
Authorization Date: 2024-05-17
Dosage Form: COMPRIMIDO
Dose: 1,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: No
Company Name: Adalvo Limited

Active Ingredients

LEVONORGESTREL

1,50 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 17, 2024

Approval ID

f7fdf5d0178969c2

Type

Standard

Back to CIMA-AEMPS Approvals